Evidence map›Paper›PMID 41100798›Full record

ArticleHepatology (Baltimore, Md.)2026

Sex and body size disparities under MELD 3.0: Evaluation of persisting gaps in liver transplant access.

Tomohiro Tanaka, Dan M Shane, Jennifer C Lai

Abstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tomohiro TanakaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.ORCID 0000-0001-6139-8444
Dan M ShaneDepartment of Health Management and Policy, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
Jennifer C LaiDivision of Gastroenterology and Hepatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0003-2092-6380

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
The spectrum of cognitive impairment including Alzheimer’s Disease and Related Dementias after liver transplantationR01AG059183 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer C. Lai · 2018 to 2026
$9.9M
Investigating the role of frailty on outcomes in acutely ill patients with cirrhosis undergoing liver transplantation in the acute care settingR01DK133527 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer C. Lai · 2023 to 2026
$2.9M
The Impact of Frailty on Liver Transplant Outcomes in Older Adults with Hepatocellular CarcinomaK24AG080021 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer C. Lai · 2023 to 2026
$755k
AHRQ HHS K08 HS029195NIA NIH HHS K24 AG080021NIA NIH HHS R01 AG059183NIDDK NIH HHS P30 DK026743NIDDK NIH HHS R01 DK133527
6 · The paper itself

Abstract

backgroundThe July 2023 implementation of MELD3.0 aimed to address longstanding sex disparities in liver transplant access. However, its impact has been understudied.

methodsWe analyzed US transplant registry data (February 4, 2020-September 30, 2024) among adult candidates for liver transplant. Using a difference-in-differences design, we assessed the impact of MELD3.0 during immediate and 3-month postimplementation ("burn-in") periods on receipt of (1) a top 5 organ offer or (2) transplant. Poisson and logistic models estimated the offer and transplant probabilities. Mediation and subgroup analyses by height were also conducted.

resultsWe analyzed 9,952,473 person-day observations from 60,159 candidates for liver transplant. Following MELD3.0, women had greater relative increases in top 5 organ offer rates (rate ratio: 1.14 1.25 1.37 at implementation; rate ratio: 1.11 1.16 1.22 at 3 mo). Pre-MELD3.0, transplant rates were lower for women than men (OR: 0.84 0.86 0.89 ). Post policy, women had greater relative improvements in transplant access than men (OR: 1.16 1.36 1.60 at implementation; OR: 1.09 1.18 1.29 at 3 mo), but this advantage diminished over time, with the model-estimated improvement for women relative to men declining to OR 0.81 by the study end. In mediation analysis, adjustment for height eliminated the difference in transplant rates by sex (OR: 0.98 1.01 1.05 ). Among taller (≥166 cm) candidates, baseline differences by sex persisted (OR: 0.89 0.92 0.96 ), but not in the shorter (<166 cm) group (OR: 0.92 0.97 1.03 ). Post policy, the benefit for women was more pronounced in shorter candidates (OR: 1.19 1.47 1.83 ).

conclusionsMELD3.0 led to early gains in transplant access for women, though this effect diminished over time and differences by sex mediated by body size persisted.

Indexed as

Body SizeEnd Stage Liver DiseaseHealthcare DisparitiesHealth Services AccessibilityLiver TransplantationTissue and Organ ProcurementAdultFemaleHumansMaleMiddle AgedRegistriesSex FactorsUnited StatesWaiting Listsbody sizedifference-in-differencesliver transplantationMELD 3.0sex disparity

Identifiers

PMID41100798
PMCPMC13576647

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.